Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|October 15, 2014
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersXinglei Chai, Tara M Friebel, Christian F Singer, et al.
JCO Precision Oncology|January 20, 2022
Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE TrialClare Gilson, Fiona Ingleby, Duncan C Gilbert, et al.
European Urology|December 3, 2014
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate CancerElena Castro, Chee Goh, Daniel Leongamornlert, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort StudyAntonis C Antoniou, Matti Rookus, Nadine Andrieu, et al.
JAMA|September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortalitySusan M Domchek, Tara M Friebel, Christian F Singer, et al.
BJU International|July 2, 2021
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screeningSarah Benafif, Holly Ni Raghallaigh, Eva McGrowder, et al.
Nature Genetics|June 13, 2017
Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumorKevin Litchfield, Max Levy, Giulia Orlando, et al.
Blood|September 9, 2018
Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphomaAmit Sud, Hauke Thomsen, Giulia Orlando, et al.
European Urology|June 14, 2020
Prostate Cancer Risk by BRCA2 Genomic RegionsTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
European Urology|September 10, 2019
Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort StudyTommy Nyberg, Debra Frost, Daniel Barrowdale, et al.
Pageof 14